[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345866-105":59,"doc-detail-345866-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ubtd1-a-prognostic-and-immune-biomarker-validated-in-thyroid-cancer-and-pan-cancer-analysis","UBTD1 - a prognostic and immune biomarker validated in thyroid cancer and pan-cancer analysis","","UBTD1 (ubiquitin domain containing 1) is examined as a biomarker and potential therapeutic target, given its links to tumorigenesis and progression. The study integrates TCGA and public databases to assess UBTD1 expression, diagnostic performance, prognostic value, epigenetic and methylation features, immune relevance, and pathway regulation across malignancies. In thyroid cancer, CCK-8, colony formation, transwell, and in vivo nude mouse xenografts validate expression and regulatory effects. Results indicate oncogenic overexpression across cancers with poor outcomes and supportive immune associations, with opposite functional effects in THCA.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ubtd1-a-prognostic-and-immune-biomarker-validated-in-thyroid-cancer-and-pan-cancer-analysis/345866/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ubtd1-a-prognostic-and-immune-biomarker-validated-in-thyroid-cancer-and-pan-cancer-analysis/345866.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is UBTD1 and why is it investigated in this study?","Question",{"text":112,"@type":113},"UBTD1 is a ubiquitin-domain-containing protein linked to tumor development and progression. The study investigates its diagnostic, prognostic, and immune-modulatory roles, especially in thyroid cancer and across multiple cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the study evaluate UBTD1 across different cancers?",{"text":117,"@type":113},"It uses TCGA and other public databases to analyze UBTD1 expression, diagnostic value, prognostic significance, epigenetic and methylation status, immune relevance, and pathway regulation across malignant tumors.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports the role of UBTD1 in thyroid cancer?",{"text":121,"@type":113},"In thyroid cancer models, the study performs in vitro assays (CCK-8, colony formation, transwell, and oris) and in vivo nude mouse xenografts. Overexpression reduces THCA proliferation, invasion, and migration, while underexpression shows opposite effects.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345866,1790196234,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Original Research PUBLISHED 08 July 2026  \nDOI 10.3389/fonc.2026.1850798  \nOPEN ACCESS  \nEDITED BY  \nRehan Khan,  \nRutgers University, Newark, United States  \nREVIEWED BY  \nShitong Su,  \nSichuan University, China Bingbing Shen,  \nSichuan University, China  \n*CORRESPONDENCE  \nChenming Guo  \n[gcm_xjmu@yeah.net](gcm_xjmu@yeah.net)  \nRECEIVED 08 April 2026  \nREVISED 22 June 2026  \nACCEPTED 22 June 2026  \nPUBLISHED 08 July 2026  \nCITATION  \nXu B, Zhang Y, Yu X and Guo C (2026) UBTD1: a prognostic and immune biomarker validated in thyroid cancer and pan-cancer analysis.  \nFront. Oncol. 16:1850798 .  \ndoi: 10.3389/fonc.2026.1850798  \nCOPYRIGHT  \n© 2026 Xu, Zhang, Yu and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nUBTD1: a prognostic and immune biomarker validated in thyroid cancer and  \npan-cancer analysis  \nBaoguo Xu 1, Yue Zhang 2, Xia Yu 3 and Chenming Guo 1*  \n1The First Afﬁliated Hospital of Xinjiang Medical University, Urumqi, China, 2 Department of Oncology, Bayingol Mongol Autonomous Prefecture People’s Hospital, Korla, China, 3 Department of Dermatology, Xinjiang Uygur Autonomous Region Children ’s Hospital, Urumqi, China  \nBackground: Ubiquitin domain containing 1 (UBTD1), a molecule intimately associated with tumorigenesis and progression, is seen as a possible cancer therapy target. However, its diagnostic value, prognostic signiﬁcance, and immunomodulatory functions of UBTD1 across cancers and in thyroid carcinoma have not yet been fully elucidated.  \nMethods: Based on TCGA and other public database resources, this research carried out an extensive examination of the expression levels, prognostic potential, diagnostic value, epigenetic modiﬁcations, methylation status, immune signiﬁcance, and pathway regulation of UBTD1, to explore its biological function in diverse malignant tumors. In addition, through in vitro experiments such as CCK-8, colony formation, transwell, and oris assays, as well as in vivo models of nude mouse xenografts, we validated the expression and regulatory function of UBTD1 in thyroid cancer.  \nResults: The study indicates that the overexpression of UBTD1 is prevalent in many cancers and correlates with poor prognosis. UBTD1 is effective to a moderate or strong degree in identifying cancerous tissues compared to healthy ones, and it serves as an independent prognostic factor in ACC, LIHC, READ, and THCA patients. UBTD1 mutations are prevalent across various malignancies and correlate with patient prognosis. In the majority of malignancies, UBTD1 expression is positively associated with m6A methylation, showing increased methylation in its promoter region. Moreover, experiments demonstrated that UBTD1 overexpression reduces THCA cell proliferation, invasion, and migration, whereas its under expression exhibited the opposite biological effects.  \nConclusion: UBTD1 can be used as a biomarker of important clinical value in pancancer. Concurrently, this research clariﬁed the expression and role of UBTD1 in THCA. These ﬁndings open new avenues for developing tumor treatments targeting UBTD1 .  \nKEYWORDS  \ndiagnosis, methylation, pan-cancer, prognosis, tumor immunity, UBTD1  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \nIntroduction  \nCancer is the world’s second leading cause of early death after cardiovascular disease, representing a critical public health priority for the 21st century (1) . How to transform cancer from an inevitable health tragedy into a preventable and controllable chronic disease has become a core issue of common concern in the global medical and public heal","cbCaihz1N9PsMu55","https://ap.wps.com/l/cbCaihz1N9PsMu55","pdf",9579533,"English","# Introduction\n## Cancer biomarkers and personalized oncology\n## Ubiquitination and UBTD1 background\n# Methods\n## Public databases and expression/prognostic analyses\n## In vitro and in vivo validation in thyroid cancer\n# Results\n## Pan-cancer expression, diagnosis, and prognosis\n## Mutations, methylation, and immune associations\n## Functional effects in THCA cells and models\n# Conclusion\n## Clinical biomarker value and implications for UBTD1-targeted therapy","[{\"question\":\"What is UBTD1 and why is it investigated in this study?\",\"answer\":\"UBTD1 is a ubiquitin-domain-containing protein linked to tumor development and progression. The study investigates its diagnostic, prognostic, and immune-modulatory roles, especially in thyroid cancer and across multiple cancers.\"},{\"question\":\"How does the study evaluate UBTD1 across different cancers?\",\"answer\":\"It uses TCGA and other public databases to analyze UBTD1 expression, diagnostic value, prognostic significance, epigenetic and methylation status, immune relevance, and pathway regulation across malignant tumors.\"},{\"question\":\"What experimental evidence supports the role of UBTD1 in thyroid cancer?\",\"answer\":\"In thyroid cancer models, the study performs in vitro assays (CCK-8, colony formation, transwell, and oris) and in vivo nude mouse xenografts. Overexpression reduces THCA proliferation, invasion, and migration, while underexpression shows opposite effects.\"}]","UBTD1 - a prognostic and immune biomarker validated in thyroid cancer and pan-cancer analysis | PDF",1790059184,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d57cfa674799e58f4a30ed32b235c4a.webp",983,1389,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8960b6c5a0bcbeceeb064a8f69d67c9.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90460ea2df9d43a7361fa55b6f1643ba.webp",981,1386,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8e00033ddbbb74f8f0443258db6dafa.webp",980,1385]